The recruitment of CAR-T cells at the tumor site was significantly enhanced with the aid of ectopic CXCR2, and CXCR2 CAR-T cells also demonstrated superior effectiveness in treating PDAC compared to control counterparts, with an increased proportion of effective memory T cells. The gene discussed is CXCR2; the disease is neoplasm.